Telmisartan Versus Amlodipine in Patients With Mild-to-Moderate Hypertension

Summary

The primary aim of the trial is the effect of telmisartan versus amlodipine in lowering ambulatory diastolic and/or systolic blood pressures in the last six hours of the dosing interval in patients with mild-to-moderate hypertension as measured by ambulatory blood pressure monitoring (ABPM)

Timeline

Start

1998-04

Primary completion

1998-12

Completion

—

Drugs

Indications